Dong S - Search Results

1

EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p.

Yi J, Ye Z, Xu H, Zhang H, Cao H, Li X, Wang T, Dong C, Du Y, Dong S, Zhou W. Yi J, et al. Among authors: dong c, dong s. Phytomedicine. 2024 Dec;135:156137. doi: 10.1016/j.phymed.2024.156137. Epub 2024 Oct 19. Phytomedicine. 2024. PMID: 39566403

2

STAT3 Inhibitors: A Novel Insight for Anticancer Therapy of Pancreatic Cancer.

Li X, Jiang W, Dong S, Li W, Zhu W, Zhou W. Li X, et al. Among authors: dong s. Biomolecules. 2022 Oct 9;12(10):1450. doi: 10.3390/biom12101450. Biomolecules. 2022. PMID: 36291659 Free PMC article. Review.

3

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Reveals That TAM2-Driven Genes Affect Immunotherapeutic Response and Prognosis in Pancreatic Cancer.

Du Y, Dong S, Jiang W, Li M, Li W, Li X, Zhou W. Du Y, et al. Among authors: dong s. Int J Mol Sci. 2023 Aug 14;24(16):12787. doi: 10.3390/ijms241612787. Int J Mol Sci. 2023. PMID: 37628967 Free PMC article.

4

Betulinic acid in the treatment of tumour diseases: Application and research progress.

Jiang W, Li X, Dong S, Zhou W. Jiang W, et al. Among authors: dong s. Biomed Pharmacother. 2021 Oct;142:111990. doi: 10.1016/j.biopha.2021.111990. Epub 2021 Aug 10. Biomed Pharmacother. 2021. PMID: 34388528 Free article. Review.

5

Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations.

Chen Z, Zhang S, Dong S, Xu H, Zhou W. Chen Z, et al. Among authors: dong s. Front Immunol. 2022 Mar 3;13:844401. doi: 10.3389/fimmu.2022.844401. eCollection 2022. Front Immunol. 2022. PMID: 35309293 Free PMC article. Review.

6

New challenges for microRNAs in acute pancreatitis: progress and treatment.

Zhou W, Dong S, Chen Z, Li X, Jiang W. Zhou W, et al. Among authors: dong s. J Transl Med. 2022 May 4;20(1):192. doi: 10.1186/s12967-022-03338-2. J Transl Med. 2022. PMID: 35509084 Free PMC article. Review.

7

Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression.

Dong S, Li W, Li X, Wang Z, Chen Z, Shi H, He R, Chen C, Zhou W. Dong S, et al. Front Immunol. 2022 Dec 12;13:1038650. doi: 10.3389/fimmu.2022.1038650. eCollection 2022. Front Immunol. 2022. PMID: 36578477 Free PMC article. Review.

8

Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer.

Li X, Jiang W, Li W, Dong S, DU Y, Zhang H, Zhou W. Li X, et al. Among authors: dong s. Oncol Res. 2023 Jun 27;31(4):505-514. doi: 10.32604/or.2023.026959. eCollection 2023. Oncol Res. 2023. PMID: 37415745 Free PMC article.

9

Integrated transcriptomics, proteomics and metabolomics-based analysis uncover TAM2-associated glycolysis and pyruvate metabolic remodeling in pancreatic cancer.

Li X, Du Y, Jiang W, Dong S, Li W, Tang H, Yi J, Zhou W, Zhang H. Li X, et al. Among authors: dong s. Front Immunol. 2023 Aug 17;14:1170223. doi: 10.3389/fimmu.2023.1170223. eCollection 2023. Front Immunol. 2023. PMID: 37662928 Free PMC article.

10

Ciprofol suppresses proliferation, invasion and migration of human pancreatic cancer cells.

Han F, Dong S, Chen Z, Dong C, Shi H, Du Y, Zhou W. Han F, et al. Among authors: dong s, dong c. Pak J Pharm Sci. 2024 Mar;37(2):327-336. Pak J Pharm Sci. 2024. PMID: 38767100

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,322 results

Search Page

Filters